NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
NASDAQ: EDSA 47.03%
$38M Defense Backlog vs. $6M Market Cap, Breakthrough Biotech Data, and the Quantum Security Land Grab
NASDAQ: MGN 34.5%
Megan Holdings Limited Announces Closing of $8.3 Million Follow-on Public Offering
NASDAQ: BYND 32.83%
Expected US Company Earnings on Wednesday, February 25th, 2026
NASDAQ: NGNE 77.39%
NASDAQ: KORE 77.39%
NASDAQ: CDIO 77.39%
NASDAQ: EDSA 77.39%
NASDAQ: MGN 77.39%
